Contact us
|
Home
|
Login
| Users Online: 320
Feedback
Subscribe
Advertise
Search
Advanced Search
Month wise articles
Figures next to the month indicate the number of articles in that month
2022
January
[
3
]
2021
December
[
1
]
November
[
3
]
September
[
1
]
May
[
1
]
April
[
3
]
January
[
1
]
2020
December
[
1
]
October
[
1
]
July
[
1
]
2019
April
[
1
]
February
[
1
]
2018
December
[
1
]
September
[
1
]
June
[
1
]
May
[
2
]
April
[
3
]
2017
December
[
1
]
November
[
1
]
October
[
1
]
September
[
1
]
July
[
1
]
June
[
1
]
April
[
2
]
March
[
1
]
February
[
2
]
2016
December
[
1
]
November
[
1
]
October
[
1
]
September
[
2
]
July
[
1
]
May
[
1
]
April
[
1
]
February
[
1
]
January
[
1
]
2015
November
[
2
]
September
[
1
]
August
[
1
]
July
[
2
]
June
[
1
]
March
[
1
]
January
[
2
]
2014
November
[
1
]
September
[
1
]
August
[
1
]
July
[
3
]
March
[
1
]
2013
September
[
1
]
August
[
1
]
January
[
1
]
2012
November
[
1
]
June
[
1
]
April
[
1
]
2011
December
[
1
]
November
[
1
]
October
[
1
]
August
[
1
]
June
[
1
]
May
[
2
]
March
[
1
]
2010
October
[
1
]
May
[
1
]
» Articles published in the past year
To view other articles click corresponding year from the navigation links on the left side.
All
|
Abstract
|
Book Review
|
Commentary
|
Editorial
|
Letters
|
Original Articles
|
Research Article
|
Review Articles
|
Technical Note
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Show all abstracts
Show selected abstracts
Export selected to
Add to my list
Technical note:
Use of a laboratory information system driven tool for pre-signout quality assurance of random cytopathology reports
Sonal Kamat, Anil V Parwani, Walid E Khalbuss, Sara E Monaco, Susan M Kelly, Luke T Wiehagen, Anthony L Piccoli, Karen M Lassige, Liron Pantanowitz
J Pathol Inform
2011, 2:42 (27 August 2011)
DOI
:10.4103/2153-3539.84279
PMID
:21969923
Background:
Quality assurance (QA) programs in cytopathology laboratories in the USA currently primarily involve the review of Pap tests per clinical laboratory improvement amendments of 1988 federal regulations. A pre-signout quality assurance tool (PQAT) at our institution allows the laboratory information system (LIS) to also automatically and randomly select an adjustable percentage of non-gynecological cytopathology cases for review before release of the final report. The aim of this study was to review our experience and the effectiveness of this novel PQAT tool in cytology.
Materials and Methods:
Software modifications in the existing LIS application (CoPathPlus, Cerner) allow for the random QA of 8% of cases prior to signout. Selected cases are assigned to a second QA cytopathologist for review and all agreement and disagreements tracked. Detected errors are rectified before the case is signed out. Data from cases selected for PQAT over an 18-month period were collected and analyzed.
Results:
The total number of non-gynecological cases selected for QA review was 1339 (7.45%) out of 17,967 cases signed out during this time period. Most (1304) cases (97.4%) had an agreement in diagnosis. In 2.6% of cases, there were disagreements, including 34 minor and only 1 major disagreement. Average turnaround time of cases selected for review was not significantly altered.
Conclusion:
The PQAT provides a prospective QA mechanism in non-gynecological cytopathology to prevent diagnostic errors from occurring. This LIS-driven tool allows for peer review and corrective action to be taken prior to reporting without delaying turnaround time, thereby improving patient safety.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (3) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Sitemap
|
What's New
Feedback
|
Copyright and Disclaimer
|
Privacy Notice
© Journal of Pathology Informatics | Published by Wolters Kluwer -
Medknow
Online since 10
th
March, 2010